Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Zipora Speiser"'
Publikováno v:
Journal of Neural Transmission. 115:107-116
This study investigated whether rasagiline and selegiline (MAO-B inhibitors) induce serotonin syndrome in fluoxetine-treated rats. Rats received rasagiline (0.1, 0.5, 2.0 mg/kg), or selegiline (0.8, 4.0, 16.0 mg/kg) (doses reflecting the clinical rat
Publikováno v:
Journal of Neural Transmission. 114:595-605
The neuroprotective effects of intravenous rasagiline were investigated in a rat model of stroke. Middle cerebral artery (MCA) occlusion was performed in male rats and the short- (neurological severity score [NSS], infarct size), intermediate- (cogni
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 319:332-339
Perinatal hypoxic injury is associated with significant neonatal morbidity and long-term neurodevelopmental complications. NAP, a peptide derived from ADNP (activity-dependent neuroprotective protein), has previously shown neuroprotective abilities i
Publikováno v:
Experimental Neurology. 184:726-736
Hypertension is one of the major risk factors of stroke and vascular dementia (VaD). We used stroke prone spontaneous hypertensive rats (SPSHRs) as a model for neuronal degeneration frequently occurring in humans with vascular disease. Recently, high
Publikováno v:
Journal of Neural Transmission. 106:593-606
Rasagiline, as the mesylate salt (TVP-1012), is a selective, potent, non-reversible MAO-B inhibitor of the propargylamine type. Current cellular and whole animal studies suggested a potential for neuroprotection by rasagiline. Rasagiline in repeat ip
Publikováno v:
Pharmacology Biochemistry and Behavior. 60:387-393
Rasagiline (N-propargyl-1(R)aminoindan) is a selective and potent MAO-B inhibitor currently under development as the mesylate salt (TVP-1012) for the treatment of various neurologic disorders. Preliminary work in adult and senescent rats, either norm
Publikováno v:
European Journal of Pharmacology. 195:75-83
Increased motor activity and poor performance in the active avoidance test were observed in the offspring of rats treated with d1-propranolol or sotalol during pregnancy, but not with atenolol and d-propranolol. All substances were administered in dr
Autor:
Paul H. Gordon, Caterina Bendotti, Jacqueline Montes, Sari Goren, Zipora Speiser, Cristina Cheroni, Eran Blaugrund, Massimo Tortarolo, Hussein Hallak
Publisher Summary Amyotrophic Lateral Sclerosis (ALS) is an age-related neurodegenerative disease affecting Motor Neurons (MNs). There is no known cure and survival extends approximately 3 years on average from symptom onset. Nearly two decades ago,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e228da26da10389ef45c4ea744aa8eaf
https://doi.org/10.1016/b978-0-12-373861-5.00019-9
https://doi.org/10.1016/b978-0-12-373861-5.00019-9
Publikováno v:
Behavioural Brain Research. 37:19-27
Wistar male rats, 3-4 months old, were made to breathe for 6 h a sub-lethal hypoxic atmosphere consisting of 8% oxygen and 92% nitrogen. Following this treatment, these rats were subjected to a series of behavioral and biochemical tests starting 30 d
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 108(8-9)
The aim of this study was to determine whether chronic treatment with the selective MAO-B inhibitor rasagiline, N-propargyl-1-(R)-aminoindan (R-PAI), can prevent or delay stroke or improve its outcome in salt-loaded stroke-prone spontaneously hyperte